PCD Pharma Franchise Opportunities in Karnataka with Daksh Diabetes and Cardiac Care
Recent health data paints a concerning picture of Karnataka’s escalating diabetes and hypertension crisis. According to the National Family Health Survey (NFHS-5), the prevalence of diabetes in Karnataka is 8.4%, higher than the national average of 7.3%. However, more localized studies reveal even more alarming figures—a community-based study in rural Dakshina Kannada found a diabetes prevalence of 31.4%, with 63.5% unaware of their condition and only 52.1% of those treated achieving adequate blood sugar control.
The state’s hypertension burden is equally severe, with 25% of women and 26.9% of men aged 15 and above having hypertension, exceeding the national averages of 21.3% and 24% respectively. A rural Bengaluru study found a diabetes prevalence of 10.9%, a prediabetes prevalence of 6.3%, and hypertension prevalence of 24.3%, with more than one-third of diabetics and three-fourths of hypertensives being newly diagnosed during screening. Karnataka has emerged as a focal point for non-communicable diseases, with 10.6% of the population now living with diabetes and a further 13.7% in the pre-diabetic stage, along with 31.5% affected by high blood pressure.
The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Karnataka families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes.
How Daksh is making a Difference in Karnataka
1. Affordable, Quality-Assured Medications
Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment.
What this means for Karnataka patients:
- Access to WHO-GMP certified medications
- Lower out-of-pocket expenses for lifelong treatments
- No compromise on quality despite affordable pricing
2. Complete Cardiac Care Portfolio
Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs:
| Product Category | Daksh Offerings | Purpose |
| ACE Inhibitors | DORAPIL (Ramipril) | Blood pressure control, heart failure treatment |
| ARBs | CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) | Hypertension management |
| Beta-Blockers | CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) | Heart rate control, heart failure |
| Calcium Channel Blockers | DUPIN (Amlodipine), CLINITAC (Cilnidipine) | Blood pressure, angina |
| Diuretics | TORDAC (Torsemide), FRUSIDIP | Fluid management in heart failure |
| Lipid Management | ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) | Cholesterol control |
3. Complete Diabetic Care Portfolio
For diabetes management, Daksh provides modern therapeutic options including:
| Product Category | Daksh Offerings |
| SGLT2 Inhibitors | DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug |
| DPP-4 Inhibitors | TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) |
| Sulfonylureas | GLIMIDAC (Glimepiride) |
| Biguanides | GLYCODIP SR (Metformin) |
| Combination Therapies | DYFOZIN M, GLIMIDAC MV (triple combination) |
4. Focus on Preventive Care
Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications:
- Liver tonics for medication-induced liver protection
- Calcium supplements for bone health (critical for diabetic patients)
- Vitamin complexes for overall metabolic support
5. Supporting Healthcare Providers across Karnataka
Daksh works with hospitals, clinics, and pharmacies across Karnataka to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses.
With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community.
Popular Locations for PCD Pharma Franchise in Karnataka
| PCD / Franchise Keywords | Product / Therapy Keywords |
| PCD pharma franchise in Bengaluru | Cardiac diabetic PCD company in Bengaluru |
| PCD pharma franchise in Mysuru | Cardiac diabetic products in Mysuru |
| PCD pharma franchise in Hubballi | Diabetic cardiac PCD franchise in Hubballi |
| PCD pharma franchise in Mangaluru | Cardiac diabetic PCD company in Mangaluru |
| PCD pharma franchise in Belagavi | Cardiac diabetic products in Belagavi |
| PCD pharma franchise in Kalaburagi | Diabetic cardiac PCD franchise in Kalaburagi |
| PCD pharma franchise in Davanagere | Cardiac diabetic PCD company in Davanagere |
| PCD pharma franchise in Ballari | Cardiac diabetic products in Ballari |
| PCD pharma franchise in Tumakuru | Diabetic cardiac PCD franchise in Tumakuru |
| PCD pharma franchise in Shivamogga | Cardiac diabetic PCD company in Shivamogga |
Conclusion
The diabetes and heart disease epidemic in Karnataka is not just a statistic—it is a reality affecting millions of families. With the state recording a diabetes prevalence of 8.4%, rural rates as high as 31.4%, and hypertension affecting 31.5%, the burden is already immense and growing. The high rates of undiagnosed disease and inadequate control create a pressing need for quality, accessible medications. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.
Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines.
Contact Daksh Diabetic and Cardiac
| Contact Method | Details |
| Office Address | Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India |
| Phone | 📞 +91 93565 60523 📞 +91 78886 02869 |
| enquirypurchase.daksh@gmail.com | |
| Contact us | https://diabetes-cardiac.com/contact-us/ |